Studies have shown that AAV‐CRISPR/Cas9‐mediated homologous directed repair of LDLR gene correction can partly salvage LDLR gene expression in vivo and efficiently improve atherosclerosis phenotypes such as cholesterol, triglyceride, and LDL‐C levels.114. Here, LDLR is linked to atherosclerosis.